Three-Dimensional Nuclear Telomere Profiling as a Biomarker for Recurrence in Oligodendrogliomas: A Pilot Study.
Adult
Aged
Biomarkers, Tumor
/ metabolism
Biopsy
Brain Neoplasms
/ diagnosis
Cell Nucleus
/ metabolism
Chromosomes, Human, Pair 1
Chromosomes, Human, Pair 19
Disease Progression
Female
Genomics
Humans
Imaging, Three-Dimensional
In Situ Hybridization, Fluorescence
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Recurrence, Local
Oligodendroglioma
/ diagnosis
Pilot Projects
Prospective Studies
Quality of Life
Telomere
/ metabolism
Treatment Outcome
gliomas
nuclear organization
oligodendroglioma
telomere
three-dimensional
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
12 Nov 2020
12 Nov 2020
Historique:
received:
11
08
2020
revised:
27
10
2020
accepted:
04
11
2020
entrez:
17
11
2020
pubmed:
18
11
2020
medline:
7
4
2021
Statut:
epublish
Résumé
Mechanisms of recurrence in oligodendrogliomas are poorly understood. Recurrence might be driven by telomere dysfunction-mediated genomic instability. In a pilot study, we investigated ten patients with oligodendrogliomas at the time of diagnosis (first surgery) and after recurrence (second surgery) using three-dimensional nuclear telomere analysis performed with quantitative software TeloView
Identifiants
pubmed: 33198352
pii: ijms21228539
doi: 10.3390/ijms21228539
pmc: PMC7696868
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Leukemia and Lymphoma Society of Canada
ID : 763110142
Références
Sci Rep. 2020 Feb 7;10(1):2086
pubmed: 32034238
Acta Neuropathol. 2015 Jun;129(6):809-27
pubmed: 25943885
J Microsc. 2001 Nov;204(Pt 2):99-107
pubmed: 11737543
Transl Oncol. 2020 Feb;13(2):346-354
pubmed: 31891871
J Neurosci Rural Pract. 2017 Oct-Dec;8(4):629-641
pubmed: 29204027
Cancer Biomark. 2017;19(2):137-144
pubmed: 28211798
Cytometry A. 2009 May;75(5):428-39
pubmed: 19097172
Neuropathology. 2014 Apr;34(2):170-8
pubmed: 24118308
Mol Neurobiol. 2018 May;55(5):3718-3724
pubmed: 28534272
Neurosurgery. 1997 Oct;41(4):878-84; discussion 884-5
pubmed: 9316050
Asian J Neurosurg. 2019 Apr-Jun;14(2):356-363
pubmed: 31143247
Hum Pathol. 2017 Nov;69:15-22
pubmed: 28549927
Int J Mol Sci. 2018 Jan 19;19(1):
pubmed: 29351238
Leukemia. 2009 Mar;23(3):565-73
pubmed: 19039323
Brain Pathol. 2002 Apr;12(2):257-9
pubmed: 11958379
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9613-8
pubmed: 15983382
BMC Cancer. 2019 Oct 17;19(1):968
pubmed: 31623593
Brain Pathol. 2008 Jul;18(3):360-9
pubmed: 18371182
BMC Biol. 2004 Jun 03;2:12
pubmed: 15176976
J Low Genit Tract Dis. 2007 Oct;11(4):265-72
pubmed: 17917571
Neuro Oncol. 2010 Jul;12(7):664-78
pubmed: 20164239
Diagn Pathol. 2019 Apr 9;14(1):29
pubmed: 30967140
PLoS One. 2011;6(7):e22000
pubmed: 21760942
Nat Genet. 2004 Sep;36(9):932-4
pubmed: 15340427
Crit Rev Oncol Hematol. 2008 Jun;66(3):262-72
pubmed: 18272388
Pediatr Neurosci. 1985-1986;12(4-5):261-5
pubmed: 3916539
J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9
pubmed: 9776413
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Lab Invest. 2003 Mar;83(3):419-28
pubmed: 12649342
Neuropathol Appl Neurobiol. 2018 Feb;44(2):139-150
pubmed: 28815663
Neoplasia. 2007 Jul;9(7):578-88
pubmed: 17710161
Acta Neuropathol. 2007 Aug;114(2):97-109
pubmed: 17618441
Neuro Oncol. 1999 Jan;1(1):52-60
pubmed: 11550302
Oncotarget. 2016 Aug 16;7(33):53392-53413
pubmed: 27438144
Neurosurg Focus. 2005 Apr 15;18(4):e7
pubmed: 15844870
Transl Oncol. 2012 Aug;5(4):269-77
pubmed: 22937179
Handb Clin Neurol. 2016;134:71-95
pubmed: 26948349
Nat Genet. 2014 Jul;46(7):731-5
pubmed: 24908248
Neuropathol Appl Neurobiol. 2013 Oct;39(6):706-17
pubmed: 23363074
J Pathol. 2012 Jan;226(1):7-16
pubmed: 22072542
Neoplasia. 2010 Feb;12(2):183-91
pubmed: 20126476
J Neurooncol. 2018 Mar;137(1):127-137
pubmed: 29204839
Neuro Oncol. 2015 Nov;17(11):1445-52
pubmed: 26014050
Adv Cancer Res. 2011;112:77-126
pubmed: 21925302
EMBO J. 2009 Sep 2;28(17):2532-40
pubmed: 19629041
J Neuropathol Exp Neurol. 2004 Apr;63(4):314-22
pubmed: 15099021
Acta Neuropathol. 2017 Jun;133(6):1001-1016
pubmed: 28255664
J Cell Sci. 2008 Jan;121 Suppl 1:1-84
pubmed: 18089652
Cancer. 1997 Feb 15;79(4):665-7
pubmed: 9024702
Science. 2011 Sep 9;333(6048):1453-5
pubmed: 21817013
Clin Cancer Res. 2012 Jun 15;18(12):3293-304
pubmed: 22539801
Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1531-1547
pubmed: 29200109
Clin Cancer Res. 2009 Oct 15;15(20):6430-7
pubmed: 19808867
Oncotarget. 2016 Oct 4;7(40):64615-64630
pubmed: 27556304
Cancer. 1996 Jan 15;77(2):373-80
pubmed: 8625247
J Neuropathol Exp Neurol. 2006 Oct;65(10):988-94
pubmed: 17021403
Front Biosci. 2000 Jan 01;5:D213-31
pubmed: 10702383
Cytometry A. 2005 Oct;67(2):144-50
pubmed: 16163697
Mutat Res. 2004 Sep;567(1):85-104
pubmed: 15341904
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Oncotarget. 2015 Apr 30;6(12):10617-33
pubmed: 25797251
Front Biosci. 2008 Jan 01;13:2075-90
pubmed: 17981693
Mol Cell Biol. 1990 Feb;10(2):518-27
pubmed: 2300052
Cancer Genet Cytogenet. 2009 Oct;194(1):12-22
pubmed: 19737649
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Cancer Res. 2006 Oct 15;66(20):9852-61
pubmed: 17047046
Adv Anat Pathol. 2018 May;25(3):143-171
pubmed: 29521646
J Cell Biochem. 2006 Apr 1;97(5):904-15
pubmed: 16408280
BMC Cancer. 2020 Jan 15;20(1):35
pubmed: 31941467
Nature. 1990 May 31;345(6274):458-60
pubmed: 2342578